MMF-Panacea Biotec

País: Nueva Zelanda

Idioma: inglés

Fuente: Medsafe (Medicines Safety Authority)

Ingredientes activos:

Mycophenolate mofetil 250mg

Disponible desde:

InterPharma (NZ) Ltd

Designación común internacional (DCI):

Mycophenolate mofetil 250 mg

Dosis:

250 mg

formulario farmacéutico:

Capsule

Composición:

Active: Mycophenolate mofetil 250mg Excipient: Croscarmellose sodium Gelatin   Indigo carmine Iron oxide red Iron oxide yellow Magnesium stearate Povidone Purified water Starch Titanium dioxide  

Unidades en paquete:

Blister pack, Aclar, 100 capsules

clase:

Prescription

tipo de receta:

Prescription

Fabricado por:

Concord Biotech Limited

indicaciones terapéuticas:

prophylaxis of acute organ rejection in patients receiving allogeneic renal transplants. prophylaxis of acute organ rejection in patients receiving allogeneic cardiac transplants. In the treated population, MMF improved survival in the first year after transplantation. prophylaxis of acute organ rejection in patients receiving allogeneic hepatic transplants.

Resumen del producto:

Package - Contents - Shelf Life: Blister pack, Aclar - 100 capsules - 24 months from date of manufacture stored at or below 25°C - Blister pack, Triplex - 100 capsules - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 100 capsules - 24 months from date of manufacture stored at or below 25°C

Fecha de autorización:

2010-07-20